Zannoni, Gian Franco
 Distribuzione geografica
Continente #
NA - Nord America 9.151
EU - Europa 7.711
AS - Asia 7.609
SA - Sud America 1.960
AF - Africa 293
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
Totale 26.758
Nazione #
US - Stati Uniti d'America 8.899
SG - Singapore 3.712
DE - Germania 1.965
CN - Cina 1.848
BR - Brasile 1.634
SE - Svezia 1.516
IT - Italia 1.318
UA - Ucraina 507
FR - Francia 501
IE - Irlanda 446
VN - Vietnam 446
IN - India 429
GB - Regno Unito 357
ID - Indonesia 298
FI - Finlandia 256
PL - Polonia 239
RU - Federazione Russa 199
TR - Turchia 153
CI - Costa d'Avorio 140
HK - Hong Kong 138
AR - Argentina 131
CA - Canada 112
BD - Bangladesh 107
NL - Olanda 95
MX - Messico 86
JP - Giappone 76
IQ - Iraq 71
EC - Ecuador 68
AT - Austria 55
KR - Corea 54
ZA - Sudafrica 50
BE - Belgio 48
ES - Italia 41
PK - Pakistan 36
IR - Iran 34
MA - Marocco 32
CO - Colombia 30
UZ - Uzbekistan 26
LT - Lituania 25
SA - Arabia Saudita 25
CL - Cile 21
KE - Kenya 21
VE - Venezuela 21
CZ - Repubblica Ceca 20
EG - Egitto 20
RO - Romania 20
PY - Paraguay 19
CH - Svizzera 18
IL - Israele 17
AZ - Azerbaigian 15
PE - Perù 14
JO - Giordania 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
AU - Australia 12
OM - Oman 12
PH - Filippine 12
NP - Nepal 11
JM - Giamaica 10
AL - Albania 9
KZ - Kazakistan 9
BO - Bolivia 8
PT - Portogallo 8
RS - Serbia 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
BH - Bahrain 7
DO - Repubblica Dominicana 7
HN - Honduras 7
HU - Ungheria 7
PA - Panama 7
TW - Taiwan 7
EU - Europa 6
KG - Kirghizistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
ET - Etiopia 5
MD - Moldavia 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BY - Bielorussia 4
DK - Danimarca 4
GT - Guatemala 4
LB - Libano 4
SN - Senegal 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
GR - Grecia 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MK - Macedonia 3
MY - Malesia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
Totale 26.712
Città #
Chandler 1.759
Singapore 1.665
Ashburn 850
Dublin 440
Beijing 423
Jacksonville 358
New York 313
San Mateo 299
Rome 284
Jakarta 269
Dallas 268
Los Angeles 258
Boston 200
Wilmington 199
Warsaw 197
Hefei 194
Nanjing 192
Ann Arbor 189
Milan 182
Hyderabad 173
Dearborn 158
Ho Chi Minh City 148
Munich 147
Princeton 147
São Paulo 144
Abidjan 140
Frankfurt am Main 126
Hong Kong 124
Houston 111
Hanoi 110
Moscow 106
Marseille 101
Fairfield 98
Cattolica 97
The Dalles 97
Izmir 95
Seattle 94
Woodbridge 94
Helsinki 85
Lawrence 79
Nürnberg 76
Redwood City 74
Nanchang 68
Buffalo 65
Tokyo 62
Bremen 55
Chicago 53
Rio de Janeiro 52
Brooklyn 51
Seoul 51
Santa Clara 49
Hangzhou 47
London 47
Brussels 46
Boardman 44
Redmond 44
Norwalk 43
Atlanta 42
Brasília 42
Turku 42
Zhengzhou 42
Kent 39
Denver 37
Tianjin 37
Lancaster 35
Düsseldorf 34
Hebei 33
Lappeenranta 33
Belo Horizonte 32
Cambridge 32
Changsha 32
Toronto 32
Jiaxing 31
Stockholm 31
Augusta 30
Phoenix 30
Vienna 30
Falkenstein 29
Kunming 29
Mountain View 29
Nuremberg 29
Shenyang 29
Baghdad 27
Curitiba 27
University Park 27
Leawood 26
Mexico City 26
Quito 26
San Francisco 26
Montreal 25
Salvador 25
Washington 25
Bexley 24
Johannesburg 24
Lauterbourg 24
Paris 23
Poplar 23
Guayaquil 22
Manchester 22
Busto Arsizio 21
Totale 13.224
Nome #
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions 404
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 294
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 283
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 197
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 183
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 179
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. 179
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 172
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions. 171
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 171
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 170
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology. 170
Application of liquid-based cytology to fine-needle aspiration biopsies of the thyroid gland 165
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 157
A case of isolated ovarian recurrence from vulvar carcinoma. 155
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 152
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 150
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 145
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 145
[Laparoscopic diagnosis of peritoneal endometriosis] 144
Should a renal biopsy be performed at the first relapse of 'clinical nephrotic syndrome'? 144
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 142
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 141
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 140
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 139
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 139
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 139
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 138
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 137
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial 137
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 136
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 135
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 134
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 134
Placental and infant metastasis of maternal melanoma: a new case. 134
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 133
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 133
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 132
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: An observational study 131
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 130
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 129
A) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation 127
Placental and infant metastasis of maternal melanoma: A new case. 127
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications 126
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 125
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 125
RNA (E6/E7) versus DNA (E6/E7) assays for risk evaluation in women infected with Human Papillomavirus (HPV) 124
Management of adnexal masses with unexpected intracystic vegetation detected during laparoscopy. 124
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 124
Placental and infant metastasis of maternal melanoma: A new case. 124
Aymptomatic intrathyroidal parathyroid adenoma: case report and differential diagnosis with thyroid neoplasms 123
Thyroid fine-needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results 120
Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? 120
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 120
Simultaneous ovarian and endometrial osseous metaplasia: a case report 118
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 117
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 116
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study 116
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 116
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 116
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 116
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 116
Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases 115
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 115
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 115
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 114
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 114
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 113
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components 111
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 111
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer 111
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 111
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 111
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 111
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
Sexual dimorphism in medulloblastoma features 110
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 109
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 108
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 108
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 107
The role of HPV detection and typing in diagnosis of pulmonary metastatic squamous cell carcinoma of the uterine cervix 107
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 107
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 107
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 106
Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors 106
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis 105
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 105
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 104
Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update 104
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 103
Morphology and immunophenotyping of a monolateral ovotestis in a 46,XderY/45,X mosaic individual with ambiguous genitalia 102
Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. 101
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 101
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 100
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 100
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 100
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 100
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 99
Totale 13.295
Categoria #
all - tutte 122.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 0 68 145 24 127 127 218 43
2021/20221.964 144 113 36 189 99 62 47 316 84 104 339 431
2022/20234.592 560 637 340 683 241 594 281 391 554 61 165 85
2023/20242.358 93 674 77 126 82 343 138 98 49 134 289 255
2024/20255.284 75 129 363 206 383 221 237 214 702 651 1.148 955
2025/20267.427 1.937 450 998 1.655 2.272 115 0 0 0 0 0 0
Totale 27.152